UMN in Japanese joint venture for cell-cultured flu vaccines
This article was originally published in Scrip
Executive Summary
The Japanese company UMN Pharma has set up a domestic joint venture for the manufacture of cell-cultured flu vaccines, which is expected to begin operations in 2012.